| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |